Ado-trastuzumab emtansine Intravenous and Revonto Injection
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Revonto Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: dantrolene
Brand name: Dantrium, Revonto, Dantrium Intravenous, Ryanodex
Synonyms: Revonto
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Rexaphenac
- Ado-trastuzumab emtansine Intravenous-Rexulti
- Ado-trastuzumab emtansine Intravenous-Reyataz
- Ado-trastuzumab emtansine Intravenous-Reyataz (Atazanavir Capsules)
- Ado-trastuzumab emtansine Intravenous-Reyataz (Atazanavir Powder for Oral Suspension)
- Ado-trastuzumab emtansine Intravenous-Reyvow
- Revonto Injection-Adox Pak 2/100
- Revonto Injection-Adoxa
- Revonto Injection-Adoxa CK
- Revonto Injection-Adoxa Pak
- Revonto Injection-Adoxa Pak 1/100
- Revonto Injection-Adoxa Pak 1/150